Anti-Human Daxx (CT)
Data
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Rabbit Immunogen PN:D262 Product Concentration 0.5 mg/ml Formulation This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative. Storage and Handling This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient RRIDAB_2829913 Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Rabbit Anti-Human Daxx recognizes an epitope near the C-terminus of mouse and human Daxx. This polyclonal antibody was purified using affinity chromatography. Background Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 and Fas. Cell death signals are transduced by death domain (DD)- containing adapter molecules and members of the ICE/CED-3 protease family. A novel DD-containing molecule was recently cloned from mouse, human and monkey and designated Daxx. Daxx binds specifically to the Fas death domain and enhances Fas induced apoptosis and activates the Jun N-terminal kinase (JNK) pathway. Daxx is widely expressed in fetal and adult human and mouse tissues indicating its important function in Fas signaling pathways. PubMed References & Citations1. Yang, X. et al. (1997) Cell 89:1067-1076 2. Kiriakidou, M. et al. (1997) DNA Cell Biol 16:1289-98 Technical ProtocolsCertificate of Analysis |
Related Products
Products are for research use only. Not for use in diagnostic or therapeutic procedures.